|
|
Volumn 353, Issue 9152, 1999, Pages 587-588
|
|
ICON2 trial. UK consensus statement on standard practice for chemotherapy in ovarian cancer.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISCA PROTOCOL;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
PACLITAXEL;
CONSENSUS DEVELOPMENT;
FEMALE;
HUMAN;
METHODOLOGY;
NOTE;
OVARY TUMOR;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CISPLATIN;
CONSENSUS DEVELOPMENT CONFERENCES;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
FEMALE;
HUMANS;
OVARIAN NEOPLASMS;
PACLITAXEL;
RESEARCH DESIGN;
|
|
EID: 0033550589
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(05)75643-9 Document Type: Letter |
|
Times cited : (2)
|
|
References (0)
|
